Traders went risk off.

Altria is an excellent income play for long-term investors.

Despite offering high dividend returns at a low price, missteps and revenue declines may dampen the appeal of Altria stock.

Discover why Altria is still a buy: 6.8% dividend, discounted valuation, FDA-approved nicotine pouches, and $85.40 bull ...

Altria Group, Inc. expects continued growth in adjusted diluted EPS and in dividends until 2028. Click here to read why MO ...

Both of these stocks are considered Dividend Kings.

The company's strong cash flow and growth from new nicotine categories can help grow the dividend over the next decade. Altria stock is still cheap for dividend investors after running up 25% this ...

Altria stock is outperforming the market this year and has a high dividend yield. Altria has several qualities that benefit its shareholders.

Altria (NYSE: MO), the top tobacco company in America, is generally a safe income play for conservative dividend investors. Its flagship Marlboro brand still controls nearly half of the retail ...

So, should you buy or sell Altria stock after the recent decline? Before addressing this, if you are looking for an upside ...

Altria's annual dividend is $4.24. The company is a Dividend King, with 56 consecutive years of increases. Altria's annual dividend is $4.24 per share ($1.06 quarterly), meaning you'd need to own 472 ...

Altria has outperformed the broader market over the past year, but analysts are cautious about the stock’s prospects.